| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/10/2004 | US20040110932 Comprises polypeptide agent of Class I cytokine receptor subfamily for prevention and treatment cell proliferation disorders; antitumor agents |
| 06/10/2004 | US20040110921 Comprises chordin-like polypeptide fo diagnosis, pre vention and treatment of bone and cancer disorders; gene therapy; antitumor agents |
| 06/10/2004 | US20040110919 Comprises toxic jellyfish protein for use as pesticide |
| 06/10/2004 | US20040110715 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 06/10/2004 | US20040110706 Nucleic acid with point mutations, deletions, insertions and/or rearrangements ; hyperthermia, myasthenia, ataxia, neuropathic and inflammatory pain; Alzheimer*s, Parkinson's disease; schizophrenia, hyperekplexia, myotonias and arrhythmia |
| 06/10/2004 | US20040110704 Decreased or deleted activity of enzyme with modified sugar chain in which 1-position of fucose is bound to 6-position of N-acetylglucosamine in reducing end; antitumor agents, cardiovascular disorders, autoimmune diseases |
| 06/10/2004 | US20040110682 Nucleic acid construct for expressing active substances which can be activated by proteases, and preparation and use |
| 06/10/2004 | US20040110677 Stimulating differentiation in growth of osteoblasts and osteoclasts; wound healing of bone fractures and de novo bone formation; osteoporosis; bone cancer treatment; polynucleotide encoding polypeptide; genetic engineering |
| 06/10/2004 | US20040110674 Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer |
| 06/10/2004 | US20040110670 Heterologous expression of neisserial proteins |
| 06/10/2004 | US20040110289 Obtaining liver cells suspension via proteolytic digestion followed by density gradient centrifugation; liver regeneration and transplantation therapy |
| 06/10/2004 | US20040110282 Cells in which activity of the protein involved in transportation of GDP-fucose is reduced or lost |
| 06/10/2004 | US20040110273 Culture chamber for biologicals |
| 06/10/2004 | US20040110269 Protection against mycobacterial infections |
| 06/10/2004 | US20040110268 Attenuated Pasteurellaceae virulence genes are identified and used to screen bactericides and produce vaccines which prevent infection |
| 06/10/2004 | US20040110255 purposes of affinity purification or detection; increased or decreased resistance to denaturation |
| 06/10/2004 | US20040110242 reacts with prothrombin forming a complex with phosphatidylserine (PS/PT) but does not react with prothrombin (PT) not forming a complex with phosphatidylserine |
| 06/10/2004 | US20040110232 Novel cark protein and nucleic acid molecules and uses therefor |
| 06/10/2004 | US20040110218 BMOG, a novel protein member of the myelin-oligodendrocyte glycoprotein family and its use for immunomodulatory purposes |
| 06/10/2004 | US20040110184 Identifying insecticidal protein specific to lepidopteran pests; cry proteins as biological pest control agents |
| 06/10/2004 | US20040110181 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 06/10/2004 | US20040110180 Comprises enzymatic polypeptide for diagnosis, treatment and prevention of cardiovascular, immune system, nervous system, lipid and cell proliferative disorders; drug screening |
| 06/10/2004 | US20040110135 Method for producing linear DNA fragments for the in vitro expression of proteins |
| 06/10/2004 | US20040110127 Screening methods for identifying compounds which decrease HIV entry into a cell |
| 06/10/2004 | US20040109865 Antibody composition-containing medicament |
| 06/10/2004 | US20040109858 Conformation-specific anti-von Willebrand factor antibodies |
| 06/10/2004 | US20040109857 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 06/10/2004 | CA2507728A1 Cell extract of escherichia coli having mutation in s12 ribosomal protein and process for producing protein in cell-free system using the same |
| 06/10/2004 | CA2507215A1 Methods for treating cancer using porimin as a target |
| 06/10/2004 | CA2504144A1 Compositions and methods for the diagnosis of immune related diseases using pro7 |
| 06/10/2004 | CA2476691A1 Novel proteins and nucleic acids encoding same |
| 06/09/2004 | EP1426764A1 Method of diagnosing or monitoring saccharometabolic error |
| 06/09/2004 | EP1426441A1 Alpha-1,2-fucosyl transferase and dna encoding the same |
| 06/09/2004 | EP1426440A1 Novel rfrp-3 and dna thereof |
| 06/09/2004 | EP1426381A1 An epithelial protein and DNA thereof for use in early cancer detection |
| 06/09/2004 | EP1425409A2 Hybrid interferon/interferon tau proteins, compositions and methods of use |
| 06/09/2004 | EP1425397A2 Modified cry3a toxins and nucleic acid sequences coding therefor |
| 06/09/2004 | EP1425396A2 Dna encoding the major allergen of plantago lanceolata pollen, pla 11 |
| 06/09/2004 | EP1425389A2 Human antibodies specific for interleukin 15 (il-15) |
| 06/09/2004 | EP1425042A1 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c5b |
| 06/09/2004 | EP1381866B1 Process for differential diagnosis of alzheimer's dementia and device therefor |
| 06/09/2004 | EP0809510B1 Lymphotoxin-alpha/beta complexes and anti-lymphotoxin-beta receptor antibodies as anti-tumor agents |
| 06/09/2004 | EP0773991B1 Active calpain expressed by baculovirus |
| 06/09/2004 | CN1503806A Pepties from the 16/6id antibody for treating SLE |
| 06/09/2004 | CN1503780A Process for producing N-formylamino acid and utilization thereof |
| 06/09/2004 | CN1502698A Methods for the recombinant production of antifusogenic peptides |
| 06/09/2004 | CN1502697A Alzhimer's disease secretase |
| 06/09/2004 | CN1502696A Alzheimer's disease secretase |
| 06/09/2004 | CN1502692A Alzheimer's disease secretase |
| 06/09/2004 | CN1502632A Novel TNFR-FC fusion protein |
| 06/09/2004 | CN1502626A Novel human protein with cancer-inhibiting function and coding sequence thereof |
| 06/09/2004 | CN1152962C Antiangiogenic peptides derived from plasminogen, its coded polynucleotide and method of inhibiting vascularization |
| 06/09/2004 | CN1152961C Transcription factor controlling phenylpropanol biosynthesis pathway |
| 06/09/2004 | CN1152960C ICAM-4 materials and methods |
| 06/09/2004 | CN1152871C Hydroxylamine derivative useful for enhancing molecular chaperon prodn. and the prep. thereof |
| 06/08/2004 | US6747136 Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen |
| 06/08/2004 | US6747134 Antibody immunologically reactive with serine protease EOS |
| 06/08/2004 | US6746871 Bacillus crystal proteins having improved insecticidal activity; immunodetection kits; transgenic plants |
| 06/08/2004 | US6746865 Nucleic acids encoding for endostatin protein |
| 06/08/2004 | US6746838 Protein which is capable of binding to any predefined nucleic acid sequence |
| 06/08/2004 | CA2262884C Egf-like factor from chromaffin granules and glia cell-derived neurotrophic factor with survival-promoting activity on daergic neurons |
| 06/08/2004 | CA2064814C Granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
| 06/03/2004 | WO2004046365A2 Interferon-alpha polypeptides and conjugates |
| 06/03/2004 | WO2004046193A1 Method of acquiring human monoclonal antibody inhibting cancer cell proliferation |
| 06/03/2004 | WO2004045553A2 Ca125 gene and its use for diagnostic and therapeutic interventions |
| 06/03/2004 | WO2004045517A2 Method for the diagnosis and treatment of vascular disease |
| 06/03/2004 | WO2004045516A2 Compositions and methods for the diagnosis and treatment of tumor |
| 06/03/2004 | WO2004045495A2 Interacting site for gp41 on gp120 of hiv-1 |
| 06/03/2004 | WO2004025416A3 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
| 06/03/2004 | WO2004020451A9 Group b streptococcal phage lysin |
| 06/03/2004 | WO2004009021A3 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 06/03/2004 | WO2003079025A3 Methods for the identification of compounds useful for the suppression of chronic neuropathic pain and compositions thereof |
| 06/03/2004 | WO2003072743A3 Method for the recombination of genetic elements |
| 06/03/2004 | WO2003064597A3 Aggrecanase molecules |
| 06/03/2004 | WO1997035010A8 Chemokine alpha 2 |
| 06/03/2004 | US20040107460 Nucleic acid constructs and methods for producing altered seed oil compositions |
| 06/03/2004 | US20040106778 Interferon gamma-like protein |
| 06/03/2004 | US20040106777 Comprises nucleotide sequences coding extracelular matrix interacting protein for screening and identifying modulators and treatment for cancers and arteriosclerosis; tissue engineering |
| 06/03/2004 | US20040106640 Aryl ether substituted imidazoquinolines |
| 06/03/2004 | US20040106183 Shingolipid ceramide deacylase gene |
| 06/03/2004 | US20040106171 Peptides with anti-hypertensive properties |
| 06/03/2004 | US20040106149 Novel gpcr hfrbn63 |
| 06/03/2004 | US20040106134 Comprises genetically engineered immunoglobulin for use in the treatment of bone disorders |
| 06/03/2004 | US20040106120 Identifying nucleotide sequence changes/polymorphism associated with abnormal cell adhesion and treating skin, asthma and chronic obstruction pulmonary disease using enzyme inhibitors |
| 06/03/2004 | US20040105865 Treatment and diagnosis of prostate cancer |
| 06/03/2004 | US20040105862 Human TIMP-1 antibodies |
| 06/03/2004 | US20040105855 Compries immunoglobulin which binds tumor necrosis factor receptor and functions as antitumor agent in the treatment of cancer |
| 06/03/2004 | US20040105854 monoclonal or polyclonal antibodies with histidine polypeptides for immunization |
| 06/03/2004 | US20040105841 Interferons, uses and compositions related thereto |
| 06/03/2004 | CA2847795A1 Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 06/03/2004 | CA2505919A1 Ca125 gene and its use for diagnostic and therapeutic interventions |
| 06/03/2004 | CA2504267A1 Interferon-alpha polypeptides and conjugates |
| 06/03/2004 | CA2483870A1 Interacting site for gp41 on gp120 of hiv-1 |
| 06/02/2004 | EP1424394A2 TAT transdominant variants from HIV virus |
| 06/02/2004 | EP1424344A1 Modified cDNA factor VIII and its derivates |
| 06/02/2004 | EP1423708A1 Compositions and methods for aa4rp assay |
| 06/02/2004 | EP1423704A1 Diagnostic and therapeutic use of f-box proteins for alzheimer's disease and related neurodegenerative disorders |
| 06/02/2004 | EP1423701A2 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| 06/02/2004 | EP1423697A2 Secreted proteins |
| 06/02/2004 | EP1423525A1 Recombinant mva capable of expressing structural hcv antigens |